Maintenance of the viral episome is essential for the cell survival of an Epstein-Barr virus positive gastric carcinoma cell line

Archives of Pharmacal Research

Volumn 32, Issue 5, 2009, Pages 729-736

  Oh, Sang Taek ^a   Kim, Myungshin ^a   Lee, Suk Kyeong ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Episome; Epstein Barr virus; Gastric carcinoma; Hydroxyurea; SiRNA

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; HYDROXYUREA; SMALL INTERFERING RNA; EBV ENCODED NUCLEAR ANTIGEN 1; EBV-ENCODED NUCLEAR ANTIGEN 1; NUCLEIC ACID SYNTHESIS INHIBITOR;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL SURVIVAL; CELL VIABILITY; EPISOME; EPSTEIN BARR VIRUS; FLUORESCENCE IN SITU HYBRIDIZATION; HELA CELL; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; STOMACH CARCINOMA; VIRUS GENOME; CARCINOMA; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PLASMID; POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STOMACH TUMOR; TIME; VIROLOGY; VIRUS CELL TRANSFORMATION;

BLOTTING, SOUTHERN; CARCINOMA; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION REGULATION, VIRAL; HELA CELLS; HERPESVIRUS 4, HUMAN; HUMANS; HYDROXYUREA; IN SITU HYBRIDIZATION, FLUORESCENCE; NUCLEIC ACID SYNTHESIS INHIBITORS; PLASMIDS; POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TIME FACTORS; TRANSFECTION;

EID: 67649383266     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-009-1512-7     Document Type: Article

References (33)

1. A. P. Burke T. S. Yen K. M. Shekitka L. H. Sobin 1990 Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction Mod. Pathol. 3 370 380
2. K. Butz T. Ristriani A. Hengstermann C. Denk M. Scheffner F. Hoppe-Seyler 2003 siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells Oncogene 22 5938 5945
3. J. Chodosh V. P. Holder Y. J. Gan A. Belgaumi J. Sample J. W. Sixbey 1998 Eradication of latent Epstein-Barr virus by hydroxyurea alters the growthtransformed cell phenotype J. Infect. Dis. 177 1194 1201
4. D. M. Dykxhoorn C. D. Novina P. A. Sharp 2003 Killing the messenger: short RNAs that silence gene expression Nat. Rev. Mol. Cell Biol. 4 457 467
5. J. Gao X. Luo K. Tang X. Li G. Li 2006 Epstein-Barr virus integrates frequently into chromosome 4q, 2q, 1q and 7q of Burkitt's lymphoma cell line (Raji) J. Virol. Methods 136 193 199
6. A. Gräslund A. Ehrenberg L. Thelander 1982 Characterization of the free radical of mammalian ribonucleotide reductase J. Biol. Chem. 257 5711 5715
7. M. L. Gulley M. Raphael C. T. Lutz D. W. Ross N. Raab-Traub 1992 Epstein-Barr virus integration in human lymphomas and lymphoid cell lines Cancer 70 185 191
8. A. H. Hall K. A. Alexander 2003 RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells J. Virol. 77 6066 6069
9. M. Heller E. Flemington E. Kieff P. Deininger 1985 Repeat arrays in cellular DNA related to the Epstein-Barr virus IR3 repeat Mol. Cell Biol. 5 457 465
10. M. Hong Y. Murai T. Kutsuna H. Takahashi K. Nomoto C. M. Cheng S. Ishizawa Q. L. Zhao R. Ogawa B. V. Harmon K. Tsuneyama Y. Takano 2006 Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells J. Cancer Res. Clin. Oncol. 132 1 8
11. M. X. Ian S. Z. Lan Z. F. Cheng H. Dan L. H. Qiong 2008 Suppression of EBNA1 expression inhibits growth of EBV-positive NK/T cell lymphoma cells Cancer Biol. Ther. 7 1602 1606
12. R. Jiang M. Kanamori Y. Satoh M. Fukuda K. Ikuta M. Murakami T. Sairenji 2003 Contrasting effects of hydroxyurea on cell growth and reduction in Epstein-Barr virus genomes in EBV-infected epithelioid cell lines vs Burkitt's lymphoma cell lines J. Med. Virol. 70 244 252
13. R. Jiang J. L. Zhang Y. Satoh T. Sairenji 2004 Mechanism for induction of hydroxyurea resistance and loss of latent EBV genome in hydroxyurea-treated Burkitt's lymphoma cell line Raji J. Med. Virol. 73 589 595
14. K. Kawa 2000 Epstein-Barr virus-associated diseases in humans Int. J. Hematol. 71 108 117
15. J. Komano M. Sugiura K. Takada 1998 Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata. J. Virol. 72 9150 9156
16. J. B. Lawrence C. A. Villnave R. H. Singer 1988 Sensitive, high-resolution chromatin and chromosome mapping in situ: presence and orientation of two closely integrated copies of EBV in a lymphoma line Cell 52 51 61
17. M. A. Lee M. E. Diamond J. L. Yates 1999 Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus J. Virol. 73 2974 2982
18. X. P. Li G. Li Y. Peng H. F. Kung M. C. Lin 2004 Suppression of Epstein-Barr virus-encoded latent membrane protein-1 by RNA interference inhibits the metastatic potential of nasopharyngeal carcinoma cells Biochem Biophys Res Commun. 315 212 218
19. H. T. Lynch W. Grady G. Suriano D. Huntsman 2005 Gastric cancer: new genetic developments J. Surg. Oncol. 90 114 133
20. T. Matsuo M. Heller L. Petti E. O'shiro E. Kieff 1984 Persistence of the entire Epstein-Barr virus genome integrated into human lymphocyte DNA Science 226 1322 1325
21. C. Mettlin 1998 Levels of epidemiologic proof in studies of diet and cancer with special reference to dietary fat and vitamin A Prog. Clin. Biol. Res. 259 149 159
22. S. T. Oh J. S. Seo U. Y. Moon K. H. Kang D. J. Shin S. K. Yoon W. H. Kim J. G. Park S. K. Lee 2004 A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer Virology 320 330 336
23. S. T. Oh J. H. Cha D. J. Shin S. K. Yoon S. K. Lee 2007 Establishment and characterization of an in vivo model for Epstein-Barr virus positive gastric carcinoma J. Med. Virol. 79 1343 1348
24. M. Okano T. G. Gross 2000 A review of Epstein-Barr virus infection in patients with immunodeficiency disorders Am. J. Med. Sci. 319 392 396
25. J. G. Park H. K. Yang W. H. Kim J. K. Chung M. S. Kang J. H. Lee J. H. Oh H. S. Park K. S. Yeo S. H. Kang S. Y. Song Y. K. Kang Y. J. Bang Y. H. Kim J. P. Kim 1997 Establishment and characterization of human gastric carcinoma cell lines Int. J. Cancer 70 443 449
26. Rickinson, A. B. and Kieff, E., Epstein-Barr virus. In "Virology" Lippincott Williams & Wilkins, Philadelphia (1996).
27. D. Shibata L. M. Weiss 1992 Epstein-Barr virus-associated gastric adenocarcinoma Am. J. Pathol. 140 769 774
28. N. Shimizu A. Tanabe-Tochikura Y. Kuroiwa K. Takada 1994 Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV J. Virol. 68 6069 6073
29. K. S. Slobod G. H. Taylor J. T. Sandlund P. Furth K. J. Helton J. W. Sixbey 2000 Epstein-Barr virus-targeted therapy for AIDS-related primary lymphoma of the central nervous system Lancet 356 1493 1494
30. K. Takada 2000 Epstein-Barr virus and gastric carcinoma Mol. Pathol. 53 255 261
31. J. van Beek A. zur Hausen E. K. Kranenbarg R. J. Warring E. Bloemena M. E. Craanen C. J. van de Velde J. M. Middeldrop C. J. Meijer A. J. van den Brule 2002 A rapid and reliable enzyme immunoassay PCR-based screening method to identify EBV-carrying gastric carcinomas Mod. Pathol. 15 870 877
32. Q. Yin E. K. Flemington 2006 siRNAs against the Epstein Barr virus latency replication factor, EBNA1, inhibit its function and growth of EBV-dependent tumor cells Virology 346 385 393
33. L. S. Young C. W. Dawson A. G. Eliopoulos 2000 The expression and function of Epstein-Barr virus encoded latent genes Mol. Pathol. 53 238 247